BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35561703)

  • 1. Serial (1-3)-beta-D-Glucan (BDG) monitoring shows high variability among premature neonates.
    Ferreras-Antolin L; Aziz N; Warris A
    Med Mycol; 2022 Jun; 60(6):. PubMed ID: 35561703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of serum (1,3)-beta-d-glucan for neonatal invasive candidiasis: systematic review and meta-analysis.
    Cohen JF; Ouziel A; Matczak S; Brice J; Spijker R; Lortholary O; Bougnoux ME; Toubiana J
    Clin Microbiol Infect; 2020 Mar; 26(3):291-298. PubMed ID: 31539634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum (1 → 3)-β-D-glucan could be useful to rule out invasive candidiasis in neonates with an adapted cut-off.
    Cliquennois P; Scherdel P; Lavergne RA; Flamant C; Morio F; Cohen JF; Launay E; Gras Le Guen C
    Acta Paediatr; 2021 Jan; 110(1):79-84. PubMed ID: 32304593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study.
    Mikulska M; Furfaro E; Magnasco L; Codda G; Giacobbe DR; Dentone C; Vena A; Marchese A; Bassetti M
    Clin Microbiol Infect; 2022 Aug; 28(8):1154.e1-1154.e3. PubMed ID: 35283316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of a Quantitative PCR-Based Assay and Beta-d-Glucan Detection for Diagnosis of Invasive Candidiasis in Very-Low-Birth-Weight Preterm Neonatal Patients (CANDINEO Study).
    Ramos JT; Villar S; Bouza E; Bergon-Sendin E; Perez Rivilla A; Collados CT; Andreu M; Reyes CS; Campos-Herrero MI; de Heredia JL; Herrera MCL; Alonso PA; Pallás-Alonso CR; Cuenca-Estrella M;
    J Clin Microbiol; 2017 Sep; 55(9):2752-2764. PubMed ID: 28659321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The added value of (1,3)-β-D-glucan for the diagnosis of Invasive Candidiasis in ICU patients: a prospective cohort study.
    Christner M; Abdennadher B; Wichmann D; Kluge S; Pepić A; Aepfelbacher M; Rohde H; Olearo F
    Infection; 2024 Feb; 52(1):73-81. PubMed ID: 37322388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of (1→3)-β-D-glucan in same-day urine and serum samples obtained from patients with haematological malignancies.
    Raggam RB; Fischbach LM; Prattes J; Duettmann W; Eigl S; Reischies F; Wölfler A; Rabensteiner J; Prueller F; Krause R; Hoenigl M
    Mycoses; 2015 Jul; 58(7):394-8. PubMed ID: 25959065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (1-3)-β-D-glucan levels in candidiasis infections in the critically ill neonate.
    Goudjil S; Kongolo G; Dusol L; Imestouren F; Cornu M; Leke A; Chouaki T
    J Matern Fetal Neonatal Med; 2013 Jan; 26(1):44-8. PubMed ID: 22913303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (1→3)-β-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people.
    White SK; Schmidt RL; Walker BS; Hanson KE
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009833. PubMed ID: 32693433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
    White PL; Price JS; Posso RB; Barnes RA
    Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.
    Martín-Mazuelos E; Loza A; Castro C; Macías D; Zakariya I; Saavedra P; Ruiz-Santana S; Marín E; León C
    Intensive Care Med; 2015 Aug; 41(8):1424-32. PubMed ID: 26134359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of (1,3)-β-D-glucan alone or combined with traditional inflammatory markers in neonatal invasive candidiasis.
    Guo J; Wu Y; Lai W; Lu W; Mu X
    BMC Infect Dis; 2019 Aug; 19(1):716. PubMed ID: 31412796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the (1,3)-β-D-glucan assay for the diagnosis of neonatal invasive yeast infections.
    Cornu M; Goudjil S; Kongolo G; Leke A; Poulain D; Chouaki T; Sendid B
    Med Mycol; 2018 Jan; 56(1):78-87. PubMed ID: 28371838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Three β-Glucan Tests for the Diagnosis of Invasive Candidiasis in Intensive Care Units.
    Kritikos A; Caruana G; Poissy J; Mamin A; Bachmann D; Pagani JL; Coste AT; Lamoth F
    J Clin Microbiol; 2023 Feb; 61(2):e0169122. PubMed ID: 36700626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Presence of (1→3)-β-D-Glucan as Prognostic Marker in Patients After Major Abdominal Surgery.
    White PL; Posso R; Parr C; Price JS; Finkelman M; Barnes RA
    Clin Infect Dis; 2021 Oct; 73(7):e1415-e1422. PubMed ID: 32914187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of (1,3)-β-D-glucan, mannan, antimannan IgG and IgM antibodies in diagnosis of invasive candidiasis.
    Li F; Yu X; Ye L; Zhou G; Wang L; Luo Y
    Med Mycol; 2019 Nov; 57(8):976-986. PubMed ID: 30820536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial.
    Bloos F; Held J; Schlattmann P; Brillinger N; Kurzai O; Cornely OA; Thomas-Rüddel D
    Trials; 2018 Sep; 19(1):472. PubMed ID: 30180873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.
    Nguyen MH; Wissel MC; Shields RK; Salomoni MA; Hao B; Press EG; Shields RM; Cheng S; Mitsani D; Vadnerkar A; Silveira FP; Kleiboeker SB; Clancy CJ
    Clin Infect Dis; 2012 May; 54(9):1240-8. PubMed ID: 22431804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood product transfusions are associated with an increase in serum (1-3)-beta-d-glucan in infants during the initial hospitalization in neonatal intensive care unit (NICU).
    Goudjil S; Chazal C; Moreau F; Leke A; Kongolo G; Chouaki T
    J Matern Fetal Neonatal Med; 2017 Apr; 30(8):933-937. PubMed ID: 27188263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida species.
    Mokaddas E; Burhamah MH; Khan ZU; Ahmad S
    BMC Infect Dis; 2010 Oct; 10():292. PubMed ID: 20923575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.